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A B S T R A C T
The aim of the study was to compare interobserver variability for The Bethesda System (TBS) and World Health Or-
ganization (WHO) classification of cervical squamous intraepithelial lesions. A total of 1,000 conventional Papanicolaou
smears (156 positive and 884 negative) were examined »blindly« by three cytologists and one cytotechnician. The degree
of observer agreement was expressed by kappa statistics using a program for the calculation of interobserver variation
and association »Agree« (Svanholm and Jergensen, 1989). Kappa () was determined for each cytologic diagnosis within
a particular classification and total for either classification. The association with and separation from other diagnoses
was determined for each cytologic diagnosis in the form of conditional probability (Pj). In WHO classification, the diag-
noses of dysplasia media and dysplasia gravis showed poor reproducibility (=0.114 and = 0.259, respectively), the di-
agnosis of dysplasia levis good reproducibility (=0.639), and the diagnosis of carcinoma in situ excellent reprodu-
cibility (=0.762). WHO classification yielded pool  of 0.741. In TBS classification, the diagnosis of LSIL showed good,
and HSIL excellent reproducibility (=0.542 and =0.763, respectively). TBS classification yielded pool  of 0.699.
Dysplasia media (Pj=0.121) and dysplasia gravis (Pj=0.274) were found to be morphologically poorly defined, and car-
cinoma in situ (Pj=0.777) and dysplasia levis (Pj=0.651) well defined diagnoses. LSIL was morphologically moderately
defined (Pj=0.587) and HSIL well defined (Pj=0.789) diagnosis. Accordingly, TBS does not substantially improve diag-
nostic reproducibility of the cytologic diagnoses of squamous intraepithelial lesions, while providing considerably less
information to the clinician than the four-grade dysplasia/CIS terminology, thus eliminating the opportunity of choosing
a different procedure for the diagnosis of dysplasia media, which is of utmost importance in the population of young
nulliparae.
Key words: observer variability, cervical cytology, intraepithelial lesions, TBS classification, WHO classification
Introduction
Grading of the intraepithelial lesion severity by semi-
quantitative criteria such as »mild«, »moderate«, »se-
vere«, »low« or »high« is a matter of the subjective judg-
ment of the cytologist and pathohistologist, which entails
considerable intra- and interobserver variability that in-
creases with the number of options among which the
morphologist may choose. Therefore, the classification of
intraepithelial lesions has over time shown a continuous
tendency to reduce the number of diagnoses from the ini-
tial three grades of dysplasia and carcinoma in situ1
through four and three grades of cervical intraepithelial
neoplasia2,3 to only two grades of squamous intraepi-
thelial lesions4,5.
The Bethesda System (TBS)4,5 uses a two-grade ter-
minology for SIL, i.e. LSIL (low-grade) and HSIL (high-
grade), based on the main virology, molecular and clinical
evidence that LSIL mostly is a transient human pa-
pilloma virus (HPV) infection, whereas HSIL is more
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commonly associated with viral persistence and higher
risk of progression6–9. This type of classification has been
supported by the results of the National Cancer Institute
(NCI) ALTS study10, which demonstrated good repro-
ducibility for LSIL and HSIL, but poor reproducibility
for further HSIL subclassification into moderate and se-
vere dysplasia or CIN2 and CIN3.
The question is whether the reproducibility of the two
intraepithelial diagnoses in TBS classification is signifi-
cantly better than the reproducibility of the four intra-
epithelial diagnoses in WHO classification, and is it of
any practical value? The aim of the present study was to
answer this question.
Materials and Methods
Study population included 1,000 selected convention-
al Papanicolaou smears obtained in daily routine by
wooden spatula and cotton swab. The findings were clas-
sified according to 1988 TBS classification, while previ-
ous terms (three stages of dysplasia and carcinoma in
situ, and three CIN stages) were used in parallel for
squamous epithelial lesions, as recommended by the au-
thors of TBS4. According to the initial cytologic evalua-
tion, there were 844 negative findings (within normal
limits, reactive and repair alterations) and 156 positive
findings (intraepithelial or invasive lesions). The smears
containing koilocytes alone and free from changes indica-
tive of intraepithelial lesion, and those with atypical
squamous cells of undetermined significance (ASCUS)
were excluded from the study.
Three cytologists and one cytotechnician, following
the mode of classification used in daily routine, examined
these 1,000 smears »blindly«. All three terms (SIL, CIN,
and dysplasia/CIS) were recorded for squamous intra-
epithelial lesions, thus making the classifications directly
comparable upon single examination.
The degree of agreement (kappa values), association
and separation of diagnoses (conditional probability)
were determined by use of the »Agree« statistical soft-
ware to calculate interobserver variation and associa-
tion, developed in 1989 by Svanholm and Jergensen11,12.
Data on WHO classification were entered first, where
the four observers classified the cytologic findings of
1,000 smears into one of the eight diagnoses: negative
finding (within normal limits, reactive and repair chan-
ges), dysplasia levis, dysplasia media, dysplasia gravis,
carcinoma in situ, squamous cell carcinoma, atypical cy-
lindrical cells of undetermined significance (AGCUS) –
endocervical and adenocarcinoma – endocervical. These
were followed by entering data on TBS classification,
where the four observers classified the cytologic findings
of 1,000 smears into one of the six findings: negative find-
ing (within normal limits, reactive and repair changes),
LSIL (dysplasia levis), HSIL (dysplasia media, dysplasia
gravis and carcinoma in situ), squamous cell carcinoma,
atypical cylindrical cells of undetermined significance
(AGCUS) – endocervical and adenocarcinoma – endo-
cervical.
The degree of agreement between the results thus ob-
tained was expressed by kappa statistics introduced by
Cohen13. Kappa is a coefficient of observer agreement,
which takes into account that part of the observed agree-
ment between observers is due to chance. Kappa is defined
as the observed agreement (Po) adjusted for chance agre-
ement (Ps), divided by the maximum possible agreement
also corrected for the chance agreement ( = Po–Ps/1–Ps).
Kappa values range from –1 to +1, with 0 representing
only chance agreement.
Borderline kappa values () set by Landis and Koch14
and Fleiss15 were used on interpretation of the results.
According to these borderline values, kappa values grea-
ter than 0.75 are taken to represent excellent agreement
beyond chance; values below 0.40 indicate agreement
that is a little better than chance agreement; and values
between 0.40 and 0.74 represent fair-to-good agreement
beyond chance.
The association or separation of diagnoses was ex-
pressed as conditional probability (Pj) and presented in
table of conditional probability. If a randomly chosen ob-
server makes a diagnosis on a random sample, the table
shows the probability for other randomly chosen observ-
ers to make the same or another diagnosis on the same
sample. The sum of each row is 1.
Finally, the results referring to the diagnosis of squa-
mous intraepithelial lesions were compared between the
two classifications of cytologic findings employed in the
study.
Results
According to WHO classification, all cytologic diagno-
ses had >0, indicating that interobserver agreement
significantly exceeded chance agreement (p<0.05, Table
1). The  values obtained for squamous intraepithelial le-
sions indicated low reproducibility for the diagnoses of
dysplasia media (=0.114) and dysplasia gravis (= 0.259),
fairly good reproducibility for the diagnosis of dysplasia
levis (=0.639), and excellent reproducibility for the di-
agnosis of carcinoma in situ (=0.762). WHO classifica-
tion yielded pool  of 0.741 for the eight diagnoses ob-
served.
According to TBS classification, both diagnoses also
yielded >0, indicating that interobserver agreement
significantly exceeded chance agreement (p<0.05, Table
2). The  values showed fairly good reproducibility for
the diagnosis of LSIL (=0.542) and excellent repro-
ducibility for the diagnosis of HSIL (=0.763). TBS clas-
sification yielded pool  of 0.699 for the six diagnoses ob-
served.
Dysplasia media (Pj=0.121) and dysplasia gravis (Pj=
0.274) were found to be morphologically poorly defined
diagnoses that showed overlapping with all other in-
traepithelial diagnoses, even with negative findings. Car-
cinoma in situ (Pj=0.777) proved to be a well defined di-
agnosis marginally overlapping with the diagnosis of
dysplasia gravis, however, a minimal probability for all
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other diagnoses was recorded. Dysplasia levis (Pj= 0.651)
was also found to be a fairly well defined diagnosis show-
ing marginal overlapping with negative findings and
minimal probability for other intraepithelial diagnoses
(Table 3).
LSIL (Pj=0.587) proved to be a morphologically mod-
erately defined diagnosis overlapping with negative find-
ings and HSIL, whereas HSIL (Pj=0.789) was found to
be a well-defined diagnosis with minimal probability for
all other diagnoses (Table 4).
Comparison of the two classifications revealed a com-
parable degree of reproducibility for the diagnoses of
LSIL and dysplasia levis (=0.542 and =0.639, respec-
tively), and for those of HSIL and carcinoma in situ
(=0.763 and =0.762, respectively), whereby additional
information on the possible presence of dysplasia media
and dysplasia gravis are unavailable on TBS.
Discussion
A certain degree of observer variability is characteris-
tic of all diagnostic tests involving individual interpreta-
tion, including cytological as well as histological interpre-
tation of intraepithelial findings, which are the reference
standard for deciding on treatment options for cervical
disease. There are many studies of inter- and intra-
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TABLE 2




(ni,j)2 pj Pj Kappaj Variance (Kappaj) Kappaj/SE
LSIL 1082 0.098 0.587 0.542 0.0002 41.97
HSIL 1488 0.111 0.789 0.763 0.0002 59.07
(ni, j)2 – sum of the squares of the number of observers who placed the ith case in the jth diagnosis, pj – proportion of the jth diagnosis, Pj
– conditional probability that the second assignment is to j, given that the first was j, Kappaj – agreement beyond chance, Variance
(Kappaj), Kappaj/SE – t-test for statistical significance to the normal distribution, LSIL – low-grade squamous intraepithelial lesion,
HSIL – high-grade squamous intraepithelial lesion
TABLE 1




(ni,j)2 pj Pj Kappaj Variance (Kappaj) Kappaj/SE
DL 369 0.031 0.651 0.639 0.0002 49.53
DM 45 0.008 0.121 0.114 0.0002 8.82
DG 142 0.020 0.274 0.259 0.0002 20.27
CIS 883 0.066 0.777 0.762 0.0002 58.99
(ni, j)2 – sum of the squares of the number of observers who placed the ith case in the jth diagnosis, pj – proportion of the jth diagnosis, Pj
– conditional probability that the second assignment is to j, given that the first was j, Kappaj – agreement beyond chance, Variance
(Kappaj), Kappaj/SE – t-test for statistical significance to the normal distribution, DL – dysplasia levis, DM – dysplasia media, DG –
dysplasia gravis, CIS – carcinoma in situ
TABLE 3
ASSOCIATIONS BETWEEN CYTOLOGIC DIAGNOSES EXPRESSED AS CONDITIONAL PROBABILITY PJ (WHO CLASSIFICATION)*
Assignment by
first observer
Probability assignment by second observer
NEG DL DM DG CIS SCC AGCUS AC
DL 0.168 0.651 0.067 0.069 0.045 0.000 0.000 0.000
DM 0.121 0.254 0.121 0.273 0.222 0.000 0.000 0.010
DG 0.128 0.111 0.115 0.274 0.368 0.000 0.004 0.000
CIS 0.026 0.021 0.028 0.108 0.778 0.021 0.003 0.015
*Read the table horizontally: If an observer has allocated an object to one category, the table calculated the probability that another
randomly selected observer will place the same case in the same or in another category. The sum of each row is 1 (total probability).
NEG – negative, DL – dysplasia levis, DM – dysplasia media, DG – dysplasia gravis, CIS – carcinoma in situ, SCC – squamous cell carci-
noma, AGCUS – atypical endocervical cylindric cells of undetermined significance, AC – adenocarcinoma
observer variability16–37, however, few have reported re-
sults in a standardized format of kappa, i.e. agreement
adjusted for chance. A kappa varying between 0.22 and
0.69 has been reported for interobserver variability in
the cytologic and histological grading of cervical lesi-
ons16,22–24.
On histology, the diagnosis of CIN1 showed low repro-
ducibility (=0.120–0.329) and that of CIN3 good rep-
roducibility (=410–0.794)16,17,25,26. The introduction of
TBS classification has resulted in higher reproducibility;
however, it still suffers from the low reproducibility of
the diagnosis of LSIL27,28. Analyzing the two classifica-
tions in parallel, McCluggage et al.29 found both to yield a
low level of reproducibility (=0.360).
Cytologic diagnoses are almost as reproducible as
histological ones, only the cytological diagnosis of LSIL
shows a higher degree of reproducibility than the histo-
logical diagnosis of these lesions30–35. In a large sample,
Stoler and Schiffman27 demonstrated the pool reproduci-
bility of LBC (liquid based cytology), colposcopy biopsy
and LEEP biopsy to be moderate and comparable (=
0.460 for cytology and colposcopy biopsy, and =0.490 for
LEEP biopsy). The low reproducibility of histology was
most evident for LSIL, which showed higher reprodu-
cibility on cytology than on histology.
Taking in consideration the etiologic association of
HPV infection and cervical carcinoma, the fact that most
low risk HPV types were associated with condylomata
and CIN1 lesions and most high risk HPV types with
CIN2/CIN3 lesions, and poor diagnostic reproducibility
of the differentiation of mild, moderate and severe dys-
plasia/CIS, the Bethesda conference participants defined
only two clinically relevant categories, i.e. low-grade
squamous intraepithelial lesion (LSIL) and high-grade
squamous intraepithelial lesion (HSIL). The classifica-
tion of LSIL included HPV, mild dysplasia, or CIN1, and
that of HSIL moderate dysplasia, severe dysplasia, CIS,
or CIN2 and CIN34–9.
However, the results of the present study showed the
two-grade TBS classification to have provided no sub-
stantial improvement of the diagnostic reproducibility of
cytology, at the same time offering considerably less in-
formation than the four-grade dysplasia/CIS termino-
logy38. The more so, pool reproducibility was even lower
(=0.699) than for the three grades of dysplasia and car-
cinoma in situ (=0.741). LSIL showed comparably mod-
erate reproducibility as dysplasia levis (=0.542 and
=0.639, respectively), whereas HSIL showed identical
reproducibility as the diagnosis of carcinoma in situ
(=0.763 and =0.762, respectively).
The diagnosis of dysplasia media or CIN2 remains du-
bious, its natural course being closer to CIN1 than CIN3
according to the rate of progression. According to litera-
ture data, 43% of CIN2 lesions show spontaneous regres-
sion, whereas 35% are persistent. To compare it with
other types of lesions, spontaneous regression has been
reported in 57% and 32%, and persistence in 32% and
56% of CIN1 and CIN3 lesions, respectively39. In line
with these rates, the clinical approach may be quite dif-
ferent in patients with CIN2 and those with CIN3 le-
sions, which is of paramount importance for the popula-
tion of young nulliparae.
Accordingly, it appears quite justifiable to single out
CIN2 (dysplasia media) from the HSIL group and differ-
entiate it as a separate diagnostic entity. However, as it
has been demonstrated to be morphologically most po-
orly defined diagnosis (Pj=0.121), it may be more suit-
able to consider it together with CIN1 due to their com-
parable natural course and identical treatment. In
Croatia, we followed such a practice until 1990, with the
cytologic finding IIIA including CIN1 and CIN240. Hav-
ing subsequently accepted TBS classification, we have
continued using the previous dysplasia/CIS, and. CIN
terminology for SIL, thus having left the possibility for a
different treatment.
Either the level of reproducibility, association with
HPV types, or biologic behavior42 has not support the
current classification into LSIL and HSIL.
Conclusion
TBS does not substantially improve diagnostic re-
producibility of the cytologic diagnoses of SIL, at the
same time providing considerably less data to the clini-
cian than the four-grade dysplasia/CIS terminology. Po-
oled reproducibility was even lower for the three degrees
of dysplasia and carcinoma in situ. LSIL was found to be
as moderately reproducible as dysplasia levis, whereas
HSIL showed excellent reproducibility, just as the diag-
nosis of carcinoma in situ.
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TABLE 4
ASSOCIATIONS BETWEEN CYTOLOGIC DIAGNOSES EXPRESSED AS CONDITIONAL PROBABILITY PJ (TBS CLASSIFICATION)*
Assignment by first
observer
Probability assignment by second observer
NEG LSIL HSIL SCC AGCUS AC
LSIL 0.298 0.587 0.111 0.000 0.004 0.000
HSIL 0.072 0.099 0.789 0.019 0.008 0.013
*Read the table horizontally: If an observer has allocated an object to one category, the table calculated the probability that another
randomly selected observer will place the same case in the same or in another category. The sum of each row is 1 (total probability).
NEG – negative; DL – dysplasia levis, DM – dysplasia media, DG – dysplasia gravis, CIS – carcinoma in situ, SCC – squamous cell carci-
noma, AGCUS – atypical endocervical cylindric cells of undetermined significance, AC – adenocarcinoma
CIN2 (dysplasia media) should be singled out from
HSIL because of its different natural course and thus dif-
ferent treatment required, and should be differentiated
as a separate diagnostic entity. However, as it is morpho-
logically the most poorly defined diagnosis, it may prove
more useful to classify it together with CIN1.
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INTEROBSERVER VARIJABILNOST U CITOLO[KOJ SUBKLASIFIKACIJI SKVAMOZNIH
INTRAEPITELNIH LEZIJA – BETHESDA SYSTEM (TBS) VS. WORLD HEALTH
ORGANIZATION (WHO)
S A @ E T A K
Cilj rada je bio usporediti interobserver varijabilnost za The Bethesda System (TBS) i World Health Organization
(WHO) klasifikaciju skvamoznih intraepitelnih lezija cerviksa uterusa. Set od 1000 konvencionalnih Papa razmaza
(156 pozitivnih i 884 negativnih) »na slijepo« su pregledala 3 citologa i jedan citotehni~ar. Stupanj slaganja je izra`en
kappa statistikom pomo}u programa za ra~unanje interobserver varijacija i asocijacija »Agree« (Svanholm i Jergensen,
1989.). Weighted  je odre|en za svaku citolo{ku dijagnozu unutar klasifikacije, kao i za klasifikacije u cijelosti. Za
svaku citolo{ku dijagnozu je odre|ena povezanost, odnosno razgrani~enost s drugim dijagnozama u obliku uvjetne
vjerojatnosti (Pj). Kod WHO klasifikacije su slabo reproducibilne dijagnoze dysplasia media (=0,114) i dysplasia gravis
(=0,259), prili~no dobro je reproducibilna dijagnoza dysplasia levis (=0,639), a odli~no je reproducibilna dijagnoza
carcinoma in situ (=0,762). Za klasifikaciju u cijelosti  je 0,741. Kod TBS klasifikacije LSIL je prili~no dobro rep-
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roducibilna dijagnoza (=0,542), dok je HSIL odli~no reproducibilna dijagnoza (=0,763). Za klasifikaciju u cijelosti 
je 0,699. Dysplasia media (P=0,121) i dysplasia gravis (Pj=0,274) su morfolo{ki slabo definirane dijagnoze, carcinoma
in situ (Pj=0,777) i dysplasia levis (Pj=0,651) su dobro definirane dijagnoze. LSIL (Pj=0,587) je morfolo{ki srednje
definirana dijagnoza, dok je HSIL (Pj=0,789) dobro definirana dijagnoza.TBS ne popravlja bitno dijagnosti~ku rep-
roducibilnost citolo{kih dijagnoza za skvamozne intraepitelne lezije, a klini~aru daje znatno manje informacija nego
~etverodijelna dysplasia / CIS terminologija i time oduzima mogu}nost razli~itog postupka za dijagnozu dysplasia media
{to je osobito va`no za populaciju mladih nulipara i trudnica.
